BR9710404A - Indu-Æo de resposta imune contra determinantes desejados - Google Patents

Indu-Æo de resposta imune contra determinantes desejados

Info

Publication number: BR9710404A
Authority: BR; Brazil
Prior art keywords: immune response; induction; response against; against desired; determinants
Prior art date: 1996-01-24

Application number

BR9710404A

Other languages

English (en)

Portuguese (pt)

Inventor

Jeffery L Alexander

Shawn Defrees

Alessandro Sette

Original Assignee

Epimmune Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-24

Filing date

1997-01-23

Publication date

1999-08-17

1997-01-23 Application filed by Epimmune Inc filed Critical Epimmune Inc

1999-08-17 Publication of BR9710404A publication Critical patent/BR9710404A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Virology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Compounds Of Unknown Constitution (AREA)
Medicines Containing Plant Substances (AREA)
Control Of High-Frequency Heating Circuits (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BR9710404A 1996-01-24 1997-01-23 Indu-Æo de resposta imune contra determinantes desejados BR9710404A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1051096P	1996-01-24	1996-01-24
PCT/US1997/001041 WO1997026784A1 (en)	1996-01-24	1997-01-23	Induction of immune response against desired determinants

Publications (1)

Publication Number	Publication Date
BR9710404A true BR9710404A (pt)	1999-08-17

Family

ID=21746084

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9710404A BR9710404A (pt)	1996-01-24	1997-01-23	Indu-Æo de resposta imune contra determinantes desejados

Country Status (12)

Country	Link
EP (1)	EP0876398B1 (2)
JP (1)	JP4063879B2 (2)
CN (1)	CN1214051A (2)
AT (1)	ATE220687T1 (2)
AU (1)	AU1582797A (2)
BR (1)	BR9710404A (2)
CA (1)	CA2242878C (2)
DE (1)	DE69714011T2 (2)
DK (1)	DK0876398T3 (2)
ES (1)	ES2177927T3 (2)
PT (1)	PT876398E (2)
WO (1)	WO1997026784A1 (2)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6528061B1 (en) *	1997-09-04	2003-03-04	Pasteur Institut	Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
EP1903056A3 (en)	2002-12-10	2008-05-07	Idm Pharma, Inc.	HLA-A1, -A2 -A3, -A24, -B7, and -B44 binding peptides comprising tumor associated antigen epitopes, and compositions thereof
AU2003285280A1 (en) *	2002-12-11	2004-06-30	Pharmexa A/S	Targeting single epitopes
ES2456666T3 (es)	2003-04-18	2014-04-23	Biotech Synergy, Inc.	Péptidos antígenos HLA-A2 asociados a un tumor y composiciones
ES2310072B1 (es)	2005-12-23	2009-11-16	Proyecto De Biomedicina Cima, S.L.	Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
US20110165067A1 (en) *	2007-08-17	2011-07-07	University Of Maryland Office Of Technology Commercialization	Carbohydrate functionalized catanionic surfactant vesicles for drug delivery
EP2391635B1 (en) *	2009-01-28	2017-04-26	Epimmune Inc.	Pan-dr binding polypeptides and uses thereof
WO2012123269A1 (en)	2011-03-11	2012-09-20	Proyecto De Biomedicina Cima, S.L.	Immunogenic compositions and methods for their use
EP2980097A4 (en) *	2013-03-29	2017-03-08	Sumitomo Dainippon Pharma Co., Ltd.	Conjugate vaccine using trimming function of erap1
MY171854A (en)	2013-03-29	2019-11-05	Sumitomo Dainippon Pharma Co Ltd	Wt1 antigen peptide conjugate vaccine
AU2014296038B2 (en)	2013-07-31	2020-09-10	Bioventures, Llc.	Compositions for and methods of treating and preventing cancer targeting tumor associated carbohydrate antigens
EP3119424A4 (en) *	2014-03-19	2017-09-13	MacKay Medical Foundation the Presbyterian Church in Taiwan MacKay Memorial Hospital	Immunogenic glycopeptides, composition comprising the glycopeptides and use thereof
EP3549957A4 (en)	2016-11-30	2020-08-05	Sumitomo Dainippon Pharma Co., Ltd.	AUXILIARY PEPTIDE WT1, AND COMBINATION OF DUDIT PEPTIDE AND CONJUGATE PEPTIDE ANTIGENIC FOR CANCER
CN107141355B (zh) *	2017-05-31	2021-05-14	中国人民解放军第四军医大学	一种htnv抗原表位线性串联多肽及表位肽-复合物四聚体和应用
CN109991422A (zh) *	2017-12-29	2019-07-09	复旦大学	基于特异抗血清的棕榈酰化修饰蛋白质的检测方法
WO2021228853A1 (en)	2020-05-11	2021-11-18	Ose Immunotherapeutics	Vaccine against sars-cov virus
CA3189004A1 (en)	2020-07-22	2022-01-27	3H Bio. Co., Ltd.	A peptide used for immunotherapeutics
KR102261457B1 (ko) *	2020-07-22	2021-06-09	(주)쓰리에이치바이오	면역 치료제용 펩타이드
WO2022268916A2 (en)	2021-06-23	2022-12-29	Ose Immunotherapeutics	Pan-coronavirus peptide vaccine
EP4508068A4 (en)	2022-04-14	2026-04-22	Hospital For Sick Children	PFCSP-BASED IMMUNOGENS AND ASSOCIATED COMPOSITION AND METHODS
WO2025093541A1 (en)	2023-10-31	2025-05-08	Ose Immunotherapeutics	Combination of interleukin 7 and tumour associated antigen vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1118572A (zh) *	1993-03-05	1996-03-13	萨依特尔有限公司	Hla-a2.1组合肽及其用途
AU698962B2 (en) *	1993-09-14	1998-11-12	Epimmune, Inc.	Alteration of immune response using pan DR-binding peptides

1997
- 1997-01-23 DE DE69714011T patent/DE69714011T2/de not_active Expired - Lifetime
- 1997-01-23 PT PT97902074T patent/PT876398E/pt unknown
- 1997-01-23 BR BR9710404A patent/BR9710404A/pt not_active IP Right Cessation
- 1997-01-23 WO PCT/US1997/001041 patent/WO1997026784A1/en not_active Ceased
- 1997-01-23 CN CN97193221A patent/CN1214051A/zh active Pending
- 1997-01-23 EP EP97902074A patent/EP0876398B1/en not_active Expired - Lifetime
- 1997-01-23 AU AU15827/97A patent/AU1582797A/en not_active Abandoned
- 1997-01-23 AT AT97902074T patent/ATE220687T1/de active
- 1997-01-23 JP JP52697997A patent/JP4063879B2/ja not_active Expired - Lifetime
- 1997-01-23 ES ES97902074T patent/ES2177927T3/es not_active Expired - Lifetime
- 1997-01-23 CA CA2242878A patent/CA2242878C/en not_active Expired - Lifetime
- 1997-01-23 DK DK97902074T patent/DK0876398T3/da active

Also Published As

Publication number	Publication date
JP2000504328A (ja)	2000-04-11
WO1997026784A1 (en)	1997-07-31
ATE220687T1 (de)	2002-08-15
DE69714011T2 (de)	2003-02-27
EP0876398B1 (en)	2002-07-17
DE69714011D1 (de)	2002-08-22
JP4063879B2 (ja)	2008-03-19
PT876398E (pt)	2002-12-31
DK0876398T3 (da)	2002-08-12
CA2242878A1 (en)	1997-07-31
EP0876398A1 (en)	1998-11-11
AU1582797A (en)	1997-08-20
ES2177927T3 (es)	2002-12-16
CN1214051A (zh)	1999-04-14
CA2242878C (en)	2010-06-22

Legal Events

Date	Code	Title	Description
2007-07-31	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 5A, 6A, 7A, 8A, 9A E 10A ANUIDADES.
2011-12-06	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1908 DE 31/07/2007.

Publication	Publication Date	Title
BR9710404A (pt)	1999-08-17	Indu-Æo de resposta imune contra determinantes desejados
EP1545597A4 (en)	2006-08-30	IMMUNOSTIMULANT COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
CY1107628T1 (el)	2013-04-18	Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
MY125202A (en)	2006-07-31	Vaccine
SG167667A1 (en)	2011-01-28	Nucleic acid compositions for stimulating immune responses
DK0585943T3 (da)	1998-09-23	Opløselige ligander for CD40
DK1303632T3 (da)	2005-01-31	Galactomannan-oligosaccharid og fremgangsmåde til fremstilling samt anvendelse heraf
ATE404667T1 (de)	2008-08-15	Chromatin-regulatorgene
BR9611727A (pt)	1999-05-25	Derivados de quínolina anti-malária
NO964238L (no)	1996-10-04	Halofantrin-fri-base for behandling av malaria og blandinger
DK1001007T3 (da)	2008-07-07	Sterolkoncentrater , anvendelse og fremstilling deraf
DE69828179D1 (de)	2005-01-20	T-zellimpfung zur behandlung von multiple sclerosis
DK1146906T3 (da)	2011-10-24	Mukosalt afgivelsessystem
ZA98420B (en)	1999-07-19	Use of pramipexole in the treatment of restless legs syndrome.
ITRM920078A1 (it)	1993-08-05	Connettore elettrico e metodo per produrlo.
NO973193D0 (no)	1997-07-09	Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
CY1106740T1 (el)	2012-05-23	Παραλλαγες του μειζονος αλλεργιογονου par j 2 του φυτου περδικακι
MD980129A (en)	2000-04-30	Antiherpetic remedy
AU6761301A (en)	2001-12-17	Adjuvant composition comprising fha protein or fragment of fha protein in free form
EP1555316A3 (en)	2008-01-30	Antigen library immunization
ATE313329T1 (de)	2006-01-15	Disaccharidderivate zur behandlung von hyperglykämien
DE50002584D1 (de)	2003-07-24	Peptid-varianten des tumormarkers muc1 und ihre verwendung
TR199800850T2 (xx)	1998-09-21	Kan� d�zenleyici bile�imler.
EP1444250A4 (en)	2006-03-08	CHIMERIC GROEL PROTEIN AND VACCINE
ITRM940133A0 (it)	1994-03-14	Dispositivo riscaldatore e sterilizzatore rapido ad induzione elettromagnetica di alta frequenza, per attrezzi di odontotecnica odontoiatria, microchirurgica, estetica e simili.